Episode Details
Back to Episodes
FDA Approves New Immunotherapy Combo for Colon Cancer
Published 17 hours ago
Description
The FDA approved atezolizumab with chemotherapy for Stage Three colon cancer patients, cutting the risk of recurrence in half in a major trial.